Head and neck cancer : An evolving treatment paradigm
β Scribed by David M. Cognetti; Randal S. Weber; Stephen Y. Lai
- Publisher
- John Wiley and Sons
- Year
- 2008
- Tongue
- English
- Weight
- 511 KB
- Volume
- 113
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Five organically impaired and depressed head and neck cancer patients had a marked therapeutic response to methylphenidate (MPD). There was a rapid remission of depressive and cognitive dysfunctions without adverse side effects. The relationship of cognitive, behavioral, and affective symptoms to br
## Abstract A study of 144 patients with cancer of the head and neck showed that 67 (46 per cent) developed recurrent cancer. Radical second treatment, almost exclusively by surgery, secured an 11 out of 67 or 16 per cent crude 5-year survival rate for recurrent head and neck cancer. Further analys
## Abstract ## Background Although existing melanoma literature provides recommendations for thinner lesions (β€1 mm) within a heterogeneous population, a focus on the head and neck group is less pervasive. ## Methods The records of 49 nodeβnegative individuals with thin head and neck melanoma th